(Q46249750)

20 December 2017

title

UDP-Gal: N-acetylglucosamine beta 1-4 galactosyltransferase expressing live attenuated parasites as vaccine for visceral leishmaniasis (English)

1 reference

20 December 2017

1 reference

visceral leishmaniasis

1 reference

inferred from title

author name string

Siddhartha Kumar Bhaumik

1

1 reference

20 December 2017

Manoj Kumar Singh

2

1 reference

20 December 2017

Subir Karmakar

3

1 reference

20 December 2017

Tripti De

4

1 reference

20 December 2017

publication date

13 November 2008

1 reference

20 December 2017

published in

Glycoconjugate Journal

1 reference

20 December 2017

volume

26

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

663-673

1 reference

20 December 2017

Second-generation vaccines against leishmaniasis

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10719-008-9212-Y

Analysis of lectin-dependent recognition of desialylated erythrocytes by Kupffer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-008-9212-Y

In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-008-9212-Y

Induction of cell-mediated immunity during early stages of infection with intracellular protozoa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-008-9212-Y

Advances in leishmaniasis

21 January 2018

1 reference

12 December 2020

Recent developments in the chemotherapy of leishmaniasis

1 reference

12 December 2020

Immunization against Leishmania donovani: glucan as an adjuvant with killed promastigotes

1 reference

12 December 2020

Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis

1 reference

12 December 2020

Development of a safe live Leishmania vaccine line by gene replacement.

1 reference

12 December 2020

Mechanism and regulation of immunoglobulin isotype switching.

1 reference

12 December 2020

Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example.

1 reference

12 December 2020

Leishmania mexicanaandLeishmania major:Attenuation of Wild‐Type Parasites and Vaccination with the Attenuated Lines

1 reference

12 December 2020

An analysis of T cell responsiveness in Indian kala-azar.

1 reference

12 December 2020

Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice

1 reference

12 December 2020

Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis

1 reference

12 December 2020

Leishmaniasis vaccine candidates for development: a global overview

1 reference

12 December 2020

Malaria: Current status of control, diagnosis, treatment, and a proposed agenda for research and development

1 reference

12 December 2020

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

1 reference

12 December 2020

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.

1 reference

12 December 2020

Leishmaniasis: current situation and new perspectives

1 reference

12 December 2020

Leishmania vaccines: old and new.

1 reference

12 December 2020

Leishmaniasis: current status of vaccine development

1 reference

12 December 2020

Regulatory T cells in the control of immune pathology.

1 reference

12 December 2020

Immunology of leishmaniasis

1 reference

12 December 2020

Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum

1 reference

12 December 2020

Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease

1 reference

12 December 2020

Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination

1 reference

12 December 2020

Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB/c mice

1 reference

12 December 2020

Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis

1 reference

12 December 2020

Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63)

1 reference

12 December 2020

Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony

1 reference

12 December 2020

Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug

1 reference

12 December 2020

Laboratory diagnosis of visceral leishmaniasis

1 reference

12 December 2020

New insight into the mechanisms underlying Th2 cell development and susceptibility to Leishmania major in BALB/c mice

1 reference

12 December 2020

Clinical and experimental advances in treatment of visceral leishmaniasis

1 reference

12 December 2020

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

12 December 2020

Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?

1 reference

12 December 2020

Infectivity and attenuation of Leishmania donovani promastigotes: association of galactosyl transferase with loss of parasite virulence

1 reference

12 December 2020

The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response

1 reference

12 December 2020

Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy.

1 reference

12 December 2020

Murine MHC polymorphism and T cell specificities

1 reference

12 December 2020

Immunization of susceptible BALB/c mice against Leishmania braziliensis. I. Resistance induced using as immunogen adherent or nonadherent cells from infected mice.

1 reference

12 December 2020

Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection

1 reference

12 December 2020

IL-12 enhances Th1-type responses in human Leishmania donovani infections

1 reference

12 December 2020

Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection

1 reference

12 December 2020

Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1.

1 reference

12 December 2020

Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis

1 reference

12 December 2020

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

1 reference

12 December 2020

CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms

1 reference

12 December 2020

Virulence attenuation of a UDP-galactose/N-acetylglucosamine beta1,4 galactosyltransferase expressing Leishmania donovani promastigote

1 reference

12 December 2020

10.1007/S10719-008-9212-Y

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017